Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Refractory Solid Tumors × Sunitinib × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 5 Gastrointestinal Stromal Tumors 2 Thyroid Neoplasms 1 Refractory Solid Tumors 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Adenoma 1

Interventions

Sunitinib 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02691793 2022-06-15

Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors

Samsung Medical Center

Phase 4 Completed

Other solid neoplasm

Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡